159 related articles for article (PubMed ID: 16439508)
41. Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.
Eterović D; Titlić M; Culić V; Zadro R; Primorac D
Clin Appl Thromb Hemost; 2007 Apr; 13(2):188-93. PubMed ID: 17456629
[TBL] [Abstract][Full Text] [Related]
42. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
43. Mutations and polymorphisms in genes affecting haemostasis components in children with thromboembolic events.
Komitopoulou A; Platokouki H; Kapsimali Z; Moschovi M; Kattamis A; Pergantou H; Aronis S
Pathophysiol Haemost Thromb; 2006; 35(5):392-7. PubMed ID: 17230042
[TBL] [Abstract][Full Text] [Related]
44. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
45. [Factor V Leiden in women with repeated IVF failures].
Ivanov P; Konova E; Gecheva S; Tavyatkovska T; Izmailov A; Komsa-Penkova R; Ivanov I; Golemanov G; Kovacheva K; Simeonova M
Akush Ginekol (Sofiia); 2013; 52(6):11-4. PubMed ID: 24501874
[TBL] [Abstract][Full Text] [Related]
46. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
47. False-negative factor V Leiden genetic testing in a patient with recurrent deep venous thrombosis.
Libby EN; Booker JK; Gulley ML; Garcia D; Moll S
Am J Hematol; 2006 Apr; 81(4):284-9. PubMed ID: 16550515
[TBL] [Abstract][Full Text] [Related]
48. [A report of two Chinese familial Budd-Chiari syndrome].
Feng B; Xu K; Jiang H; Fu W; Li H; Guo M; Liu X; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):482-4. PubMed ID: 11877025
[TBL] [Abstract][Full Text] [Related]
49. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
[TBL] [Abstract][Full Text] [Related]
50. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
51. Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study.
Benfield T; Ejrnaes K; Juul K; Østergaard C; Helweg-Larsen J; Weis N; Munthe-Fog L; Kronborg G; Andersen MR; Tybjaerg-Hansen A; Nordestgaard BG; Garred P
Crit Care; 2010; 14(2):R28. PubMed ID: 20202226
[TBL] [Abstract][Full Text] [Related]
52. Interference of factor V Leiden on protein S activity: evaluation of a new prothrombin time-based assay.
Tripodi A; Asti D; Chantarangkul V; Biguzzi E; Mannucci PM
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):543-6. PubMed ID: 17762529
[TBL] [Abstract][Full Text] [Related]
53. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure.
Qublan HS; Eid SS; Ababneh HA; Amarin ZO; Smadi AZ; Al-Khafaji FF; Khader YS
Hum Reprod; 2006 Oct; 21(10):2694-8. PubMed ID: 16835215
[TBL] [Abstract][Full Text] [Related]
54. Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome.
Adamzik M; Frey UH; Riemann K; Sixt S; Lehmann N; Siffert W; Peters J
Crit Care Med; 2008 Jun; 36(6):1776-9. PubMed ID: 18496379
[TBL] [Abstract][Full Text] [Related]
55. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
56. The association between activated protein C ratio and Factor V Leiden are gender-dependent.
Hansen RS; Nybo M
Clin Chem Lab Med; 2019 Jul; 57(8):1229-1234. PubMed ID: 30903752
[TBL] [Abstract][Full Text] [Related]
57. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
58. Factor V Leiden mutation accelerates the onset of natural menopause.
van Asselt KM; Kok HS; Peeters PH; Roest M; Pearson PL; te Velde ER; Grobbee DE; van der Schouw YT
Menopause; 2003; 10(5):477-81. PubMed ID: 14501610
[TBL] [Abstract][Full Text] [Related]
59. Paternal thrombophilic gene mutations are not associated with recurrent miscarriage.
Toth B; Vocke F; Rogenhofer N; Friese K; Thaler CJ; Lohse P
Am J Reprod Immunol; 2008 Oct; 60(4):325-32. PubMed ID: 18754836
[TBL] [Abstract][Full Text] [Related]
60. Increased titer of anti-beta2-glycoprotein I IgG antibody among factor V Leiden carriers during oral contraceptive use.
Póka R; Vad S; Lakos G; Bereczki Z; Kiss E; Sipka S
Contraception; 2004 Jan; 69(1):27-30. PubMed ID: 14720616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
